Sentences with phrase «early stage cancer research»

One of the most promising fields of early stage cancer research, still only undertaken by a few scientific groups, is focused on interfering in telomere lengthening.

Not exact matches

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

And animal research has linked even low - level exposure to everything from female reproductive disorders, early puberty, early - stage breast and prostate cancer, and decreased sperm count to attention and developmental problems.

Dr Catherine Pickworth from Cancer Research UK, said: «This early stage study adds to the growing evidence that some men with prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation treaCancer Research UK, said: «This early stage study adds to the growing evidence that some men with prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation treacancer could benefit from being given PARP inhibitors alongside hormone deprivation treatment.

Caetano Reis e Sousa, head of the immunobiology lab at Cancer Research UK's London Research Institute, sounds says the work is «exciting» but cautions that it is at an early stage.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

Professor Arnie Purushotham, Cancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curinCancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curincancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curing her.

Adding two blood - borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer InstCancer Center reports in the Journal of the National Cancer InstCancer Institute.

With obesity rates climbing during the past 20 years within the United States and colon cancer being the second - leading killer of men and women in the nation, these facts compelled Fenton and her team to conduct research which could identify the specific biomarkers of obesity and early - stage colon cancer and help in prevention efforts.

Cancer Research UK's hunt for finding early stages of aggressive prostate cancer is notCancer Research UK's hunt for finding early stages of aggressive prostate cancer is notcancer is not over.

«If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,» said Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry.

The Early Detection Initiative is an organizational structure within Fred Hutchinson Cancer Research Center to acknowledge and support the many faculty who for years have devoted their research to the discovery of the most effective ways to find and treat cancer at its earliest sCancer Research Center to acknowledge and support the many faculty who for years have devoted their research to the discovery of the most effective ways to find and treat cancer at its earliestResearch Center to acknowledge and support the many faculty who for years have devoted their research to the discovery of the most effective ways to find and treat cancer at its earliestresearch to the discovery of the most effective ways to find and treat cancer at its earliest scancer at its earliest stages.

Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric oncology research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast cancer would increase while the incidence of advanced stage cancer would decrease because any cancer would have been detected at an earlier stage.

The DNA Repair Research Project is still in its early stages, but members of the group are committed to helping in the fight against cancer.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

Initial results were announced from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, Inc..

A «pill on a string» developed by researchers at the University of Cambridge could help doctors detect esophageal cancer — cancer of the gullet — at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.

When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer Ccancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer CCancer Center.

Maggie Blanks, Pancreatic Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early cancer at an early stage.

A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine.

But this is early laboratory research and the next stage is for clinical trials to confirm whether resveratrol has the same effects in people at high risk of bowel cancer.»

Dr Lara Bennett, Science Communications Manager at Worldwide Cancer Research added «This is another great example of the importance of early - stage, discovery rResearch added «This is another great example of the importance of early - stage, discovery researchresearch.

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Ccancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer CCancer Center.

Although the research is at an early stage, our findings may have an important impact in the way we treat patients with bowel cancer in the future.»

Cancer cells are on the move in the bloodstream in the very early stage of pancreatic cancer, and can be detected before cancer is diagnosed, according to research by the University of Michigan Health SCancer cells are on the move in the bloodstream in the very early stage of pancreatic cancer, and can be detected before cancer is diagnosed, according to research by the University of Michigan Health Scancer, and can be detected before cancer is diagnosed, according to research by the University of Michigan Health Scancer is diagnosed, according to research by the University of Michigan Health System.

«We found that having elevated levels of IL - 15 in the gut could initiate all the early stages of celiac disease in those who were genetically susceptible, and that blocking IL - 15 could prevent the disease in our mouse model,» said Bana Jabri, MD, PhD, associate professor of medicine and pathology, co-director of the Digestive Disease Research Core Center and a member of the Celiac Disease Center and Comprehensive Cancer Center at the University of Chicago.

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andCancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

Lentiviral vectors are promising agents for cancer immunotherapy, but this research is still in the pre - clinical / early clinical stages.

There are now multiple immunotherapies targeting clearance of alpha - synuclein from the brain in early - stage clinical trials, and multiple trials underway or in the works on the next generation of cell replacement therapies for dopaminergic neurons, including the TRANSEURO trial; the Summit4StemCell initiative, put together by Jeanne Loring — a researcher at The Scripps Research Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist LorenzResearch Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist Lorenzresearch into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist Lorenz Studer.

Cecil and Linda Sewell's gifts to the UNC Lineberger Seed Grant Program have propelled forward essential, early - stage cancer research.

Through basic and clinical biomedical research and training, NCI conducts and supports research that will lead to a future in which we can prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we can not eliminate so they become manageable, chronic diseases.

Despite ongoing efforts toward finding novel entities for the treatment of the most challenging cancers, translation into patient benefit has been slow due to the fact that translational cancer research from early drug discovery to late stage drug development and assessment in clinical trials is a long process.

In concert with this research, our scientists are developing new drugs to stop cancers in the very earliest stages of growth.

THURSDAY, Jan. 18, 2018 (HealthDay News)-- A simple, cheap blood test to detect colon cancer — even in its early stages — appears highly effective and accurate, new research indicates.

This exciting technology in development by Dr. Wong and his research department is in its early stages and hold much promise as a future cancer treatment.

Oats are being extensively studied in many other areas, such as in cancer research, which is still in its early stages.

Dr. Dean Ornish revolutionized medicine by directing clinical research proving — for the first time — that heart disease and early - stage prostate cancer may be stopped or even reversed by his program of comprehensive lifestyle changes, without drugs or surgery.

«Detection of early - stage cancers is the real holy grail in bowel cancer diagnosis because surgery can cure up to 90 % of patients who present with early - stage disease,» Trevor Lockett, a bowel cancer researcher with the Commonwealth Scientific and Industrial Research Organization in Australia, told Bloomberg News.

A German research report revealed that dogs are able to find early - stage lung cancer, and countless reports have revealed that canines can sniff a cancerous growth in humans long before the growth is visible with the naked human eye.

In an interdisciplinary collaboration, the University of Pennsylvania School of Veterinary Medicine's Working Dog Center (photo above courtesy of University of Pennsylvania), the School of Arts and Science's Department of Physics and Astronomy, Penn Medicine's Division of Gynecologic Oncology, and the Monell Chemical Senses Center have joined together for a research investigation using canine olfaction, along with chemical and nanotechnology analysis, to detect early - stage human ovarian cancer.

Tags for this Online Resume: Biotechnology, Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio, Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market Analysis, Segmentation, Targeting, Companion Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales Management, Communication Plan, Publication Plan, Project Management, Genetic, Genomic, Lifecycle, Long Range, Device, Late Stage, Direct Report, Indirect Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer